Should FDA's info be in all DTC ads?

First consumers, now Congress. Two lawmakers asked the FDA yesterday to mandate that all TV ads for prescription drugs include contact info for patients to report serious side effects to the agency. The impetus? A Consumer Reports poll that showed 16 respondents had a side effect serious enough to send them to the doctor or hospital--but 35 percent of respondents didn't know they could report side effects to the FDA.

FDA tracks side effects from prescription and OTC meds, but officials estimate they learn about fewer than 10 percent of drug reactions. Consumers Union, which publishes Consumer Reports, sent the agency a petition with 55,000 signatures, requesting that a toll-free number and web address be included in TV drug ads. An agency spokeswoman said it's reviewing the petition.

Already, Congress passed legislation requiring contact info to be placed in all DTC print ads and calling for an FDA study of doing the same in TV commercials. That study is still ongoing, the spokeswoman said.

- check out the Consumers Union survey
- read the Los Angeles Times story
- see the item in the WSJ Health Blog

ALSO: The FDA appears to be close to unveiling its plans for a national surveillance network to keep tabs on drug safety. The "Sentinel" project has to address a number of key questions first, though. Such as, how will prescription info be kept private and secure? And how will the system be insulated from political and industry influence? Report

Related Articles:
FDA to study TV drug ad imagery. Report
Survey: No doubt DTC ads work. Report
Watchdogs circling DTC drug commercials. Report
Study: DTC ad spending on the rise. Report
Does the FDA do enough to regulate drug ads? Report

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

Roche and Blueprint's RET inhibitor Gavreto has won FDA go-ahead to treat certain types of thyroid cancer, leveling the field with Lilly's Retevmo.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.